Φορτώνει......
Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma
Soft tissue sarcomas (STSs) are a rare cancer type. Almost half are unresponsive to multi‐pronged treatment and might therefore benefit from biologically targeted therapy. An emerging target is glycogen synthase kinase (GSK)3β, which is implicated in various diseases including cancer. Here, we inves...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004542/ https://ncbi.nlm.nih.gov/pubmed/31808966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14271 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|